13D Filing: Novo A/s and Htg Molecular Diagnostics Inc (NASDAQ:HTGM)

Page 2 of 4 – SEC Filing


CUSIP No.: 40434H 10 4
  1. 

Name of
Reporting Person:

Novo A/S

  2.

Check the Appropriate Box if a Member
of Group (See Instructions):

(a)  ☐        (b)  ☒

  3.

SEC Use Only:

  4.

Source of Funds:

WC

  5.

Check if Disclosure of Legal
Proceedings is Required Pursuant to Items 2(d) or 2(e):

  6.

Citizenship or Place of
Organization:

Denmark

Number of

Shares

Beneficially

Owned By

Each

Reporting

Person With:

  7. 

Sole Voting Power:

1,280,185

  8.

Shared Voting Power:

0

  9.

Sole Dispositive Power:

1,280,185

10.

Shared Dispositive Power:

0

11.

Aggregate Amount Beneficially Owned by Each Reporting Person:

1,280,185

12.

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares: ☐

13.

Percent of Class Represented By Amount
In Row (11):

15.9% (1)

14.

Type of Reporting Person:

CO

(1) Based upon 8,052,451 shares of the Issuers Common Stock outstanding on March 17, 2017 as reported in the Issuers Annual Report on Form 10-K filed with the Securities and Exchange Commission (the
Commission) on March 23, 2017.

2

Follow Htg Molecular Diagnostics Inc (NASDAQ:HTGM)